Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed Study

NCT01654718 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Pantoprazole
DRUG: Pantoprazole

Sponsor

Ranbaxy Laboratories Limited